GBM is characterized by the defect in apoptotic signaling (Bax/Bcl-2 down-regulation) and high proliferation, down-regulation of p53 (as a tumor suppressor gene), and uncontrolled cell cycle (Krakstad and Chekenya, 2010 ▶). This evidence concerns the gene TP53 and glioblastoma.